Clinical Trials Directory

Trials / Completed

CompletedNCT04401280

Bioactive Glass in the Treatment of Enamel White Spot Lesions

Effectiveness of Novel Bioactive Glass in the Treatment of Enamel White Spot Lesions : A Randomized Controlled Trial

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Rania Salah · Academic / Other
Sex
All
Age
14 Years – 26 Years
Healthy volunteers
Accepted

Summary

the aim of this study is to evaluate the effectiveness of BiominF® and Novamin® in comparison to Casein phosphopeptide-amorphous calcium phosphate (CPP-ACP) in the treatment of enamel white spot lesions

Conditions

Interventions

TypeNameDescription
DRUGBiominFin office application of bioactive glass followed by self administered application by the patient until a point of white spot remineralization is reached
DRUGNovaminin office application of bioactive glass followed by self administered application by the patient until a point of white spot remineralization is reached
DRUGCPP-ACPapplied in accordance with the manufacturer's specifications

Timeline

Start date
2020-06-01
Primary completion
2021-06-30
Completion
2021-06-30
First posted
2020-05-26
Last updated
2021-10-19

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT04401280. Inclusion in this directory is not an endorsement.